Is it an E lesion or stage IV? An unsettled issue in Hodgkin's disease staging

J. M. Connors, Paul Klimo

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

To determine whether recognized experts in the area of Hodgkin's disease would agree on the determination of stage when various types of extranodal disease are present, we asked senior investigators at 15 major centers to assign a stage to four different patients. In general, these experts agreed in cases representing the extremes of difference between localized and distant extranodal disease. However, when presented with patients with nearby but not contiguous extranodal disease of lung or bone, one half of the experts classified this as an E lesion and one half as stage IV. This disagreement in stage assignment has implications not only for individual patient treatment, but also for reporting of clinical trials. Over-assignment of stage IV has the practical result of 'impoving' the results of treatment of both low stage (by removing higher risk patients) and advanced stage patients (by including better risk patients). Papers reporting the results of treatment of Hodgkin's disease should include information concerning how patients with extranodal disease were separated into those with E lesions and those with stage IV disease.

Original languageEnglish (US)
Pages (from-to)1421-1423
Number of pages3
JournalJournal of Clinical Oncology
Volume2
Issue number12
DOIs
StatePublished - Jan 1 1984
Externally publishedYes

Fingerprint

Hodgkin Disease
Bone Diseases
Lung Diseases
Therapeutics
Research Personnel
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Is it an E lesion or stage IV? An unsettled issue in Hodgkin's disease staging. / Connors, J. M.; Klimo, Paul.

In: Journal of Clinical Oncology, Vol. 2, No. 12, 01.01.1984, p. 1421-1423.

Research output: Contribution to journalArticle

@article{9b75711d91734502b0ca24902618c132,
title = "Is it an E lesion or stage IV? An unsettled issue in Hodgkin's disease staging",
abstract = "To determine whether recognized experts in the area of Hodgkin's disease would agree on the determination of stage when various types of extranodal disease are present, we asked senior investigators at 15 major centers to assign a stage to four different patients. In general, these experts agreed in cases representing the extremes of difference between localized and distant extranodal disease. However, when presented with patients with nearby but not contiguous extranodal disease of lung or bone, one half of the experts classified this as an E lesion and one half as stage IV. This disagreement in stage assignment has implications not only for individual patient treatment, but also for reporting of clinical trials. Over-assignment of stage IV has the practical result of 'impoving' the results of treatment of both low stage (by removing higher risk patients) and advanced stage patients (by including better risk patients). Papers reporting the results of treatment of Hodgkin's disease should include information concerning how patients with extranodal disease were separated into those with E lesions and those with stage IV disease.",
author = "Connors, {J. M.} and Paul Klimo",
year = "1984",
month = "1",
day = "1",
doi = "10.1200/JCO.1984.2.12.1421",
language = "English (US)",
volume = "2",
pages = "1421--1423",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "12",

}

TY - JOUR

T1 - Is it an E lesion or stage IV? An unsettled issue in Hodgkin's disease staging

AU - Connors, J. M.

AU - Klimo, Paul

PY - 1984/1/1

Y1 - 1984/1/1

N2 - To determine whether recognized experts in the area of Hodgkin's disease would agree on the determination of stage when various types of extranodal disease are present, we asked senior investigators at 15 major centers to assign a stage to four different patients. In general, these experts agreed in cases representing the extremes of difference between localized and distant extranodal disease. However, when presented with patients with nearby but not contiguous extranodal disease of lung or bone, one half of the experts classified this as an E lesion and one half as stage IV. This disagreement in stage assignment has implications not only for individual patient treatment, but also for reporting of clinical trials. Over-assignment of stage IV has the practical result of 'impoving' the results of treatment of both low stage (by removing higher risk patients) and advanced stage patients (by including better risk patients). Papers reporting the results of treatment of Hodgkin's disease should include information concerning how patients with extranodal disease were separated into those with E lesions and those with stage IV disease.

AB - To determine whether recognized experts in the area of Hodgkin's disease would agree on the determination of stage when various types of extranodal disease are present, we asked senior investigators at 15 major centers to assign a stage to four different patients. In general, these experts agreed in cases representing the extremes of difference between localized and distant extranodal disease. However, when presented with patients with nearby but not contiguous extranodal disease of lung or bone, one half of the experts classified this as an E lesion and one half as stage IV. This disagreement in stage assignment has implications not only for individual patient treatment, but also for reporting of clinical trials. Over-assignment of stage IV has the practical result of 'impoving' the results of treatment of both low stage (by removing higher risk patients) and advanced stage patients (by including better risk patients). Papers reporting the results of treatment of Hodgkin's disease should include information concerning how patients with extranodal disease were separated into those with E lesions and those with stage IV disease.

UR - http://www.scopus.com/inward/record.url?scp=0021713541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021713541&partnerID=8YFLogxK

U2 - 10.1200/JCO.1984.2.12.1421

DO - 10.1200/JCO.1984.2.12.1421

M3 - Article

VL - 2

SP - 1421

EP - 1423

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 12

ER -